Hoque Md Tozammel, Shah Arpit, More Vijay, Miller David S, Bendayan Reina
Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.
Laboratory of Signal Transduction, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, USA.
J Neurochem. 2015 Dec;135(6):1113-22. doi: 10.1111/jnc.13389. Epub 2015 Nov 13.
Breast cancer resistance protein (Bcrp/Abcg2) localized at the blood-brain barrier (BBB) limits permeability into the brain of many xenobiotics, including pharmacological agents. Peroxisome proliferator-activated receptor α (Pparα), a ligand-activated transcription factor, primarily involved in lipid metabolism, has been shown to regulate the functional expression of Bcrp in human cerebral microvascular endothelial cells (hCMEC/D3). The aim of this study was to investigate ex vivo and in vivo, the regulation of Bcrp by Pparα in an intact BBB. Ex vivo quantitative real-time PCR and immunoblot analyses showed significant up-regulation of Abcg2/Bcrp mRNA and protein levels in CD-1 mouse brain capillaries incubated with clofibrate, a Pparα ligand. Fluorescence-based transport assays in CD-1 and C57BL/6 brain capillaries showed that exposure to clofibrate significantly increased Bcrp transport activity. This increase was not observed in capillaries isolated from Pparα knockout mice. In vivo, we found: i) significant Bcrp protein up-regulation in clofibrate-dosed CD-1 and C57BL/6 capillary lysates, but no effect in Pparα knockout capillary lysates, and ii) significantly increased Bcrp transport activity in capillaries isolated from clofibrate-treated mice. These results demonstrate an increase in Bcrp functional expression by Pparα in brain capillaries, and suggest that Pparα is another nuclear receptor that can contribute to the regulation of membrane efflux transporters and drug permeability at the BBB. We propose the involvement of the following pathways in clofibrate-mediated induction of the drug transporter Abcg2/Bcrp mRNA, protein expression and function by the nuclear receptor Pparα, in mouse brain capillary endothelial cells. Upon activation with clofibrate (Pparα, ligand), Pparα complex translocates from the cytoplasm into the nucleus and further recruits coactivators and transcription machinery which induce the transcription of Abcg2 gene and ultimately results in upregulation of Bcrp protein expression and function. These findings have significant implications since Bcrp is known to play an important role at the BBB in preventing the permeability of several xenobiotics and drugs into the brain.
乳腺癌耐药蛋白(Bcrp/Abcg2)定位于血脑屏障(BBB),限制了包括药物制剂在内的许多外源性物质进入大脑的通透性。过氧化物酶体增殖物激活受体α(Pparα)是一种配体激活的转录因子,主要参与脂质代谢,已被证明可调节人脑血管内皮细胞(hCMEC/D3)中Bcrp的功能表达。本研究的目的是在完整的血脑屏障中,在体外和体内研究Pparα对Bcrp的调节作用。体外定量实时PCR和免疫印迹分析表明,用Pparα配体氯贝丁酯孵育的CD-1小鼠脑微血管中,Abcg2/Bcrp mRNA和蛋白水平显著上调。基于荧光的转运试验在CD-1和C57BL/6脑微血管中表明,暴露于氯贝丁酯可显著增加Bcrp转运活性。在从Pparα基因敲除小鼠分离的微血管中未观察到这种增加。在体内,我们发现:i)氯贝丁酯给药的CD-1和C57BL/6微血管裂解物中Bcrp蛋白显著上调,但在Pparα基因敲除微血管裂解物中无影响;ii)从氯贝丁酯处理的小鼠分离的微血管中Bcrp转运活性显著增加。这些结果表明Pparα可增加脑微血管中Bcrp的功能表达,并提示Pparα是另一种可有助于调节血脑屏障处膜外排转运体和药物通透性的核受体。我们提出以下途径参与氯贝丁酯介导的核受体Pparα在小鼠脑微血管内皮细胞中诱导药物转运体Abcg2/Bcrp mRNA、蛋白表达和功能的过程。在用氯贝丁酯(Pparα配体)激活后,Pparα复合物从细胞质转运到细胞核,并进一步募集共激活因子和转录机制,从而诱导Abcg2基因的转录,最终导致Bcrp蛋白表达和功能上调。这些发现具有重要意义,因为已知Bcrp在血脑屏障中对防止几种外源性物质和药物进入大脑起着重要作用。